Drug Delivery Systems Market Share

North America Market Forecasts

By the end of 2037, the North American drug delivery systems market is anticipated to have the greatest revenue share of 35% worldwide. Longer hospital stays in the area are likely to fuel the market expansion for drug delivery systems in North America during the anticipated time frame. According to a paper published in April 2021, Canada experienced approximately 3 million acute inpatient hospitalizations in the years 2019–2020. The region's delivery systems are expected to improve as a result of these hospitalizations.

Europe Market Statistics

On the other side, Europe is anticipated to maintain a sizable market share during the projection period. This is explained by the region's growing recognition of cutting-edge medication delivery methods and acceptance of cutting-edge technology. The launch of novel medication delivery systems by important stakeholders is also projected to fuel regional market expansion, as are clinical studies for crucial governance permissions for innovative medicines.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of drug delivery systems is evaluated at USD 50.58 billion.

The drug delivery systems market size was over USD 47.47 billion in 2024 and is expected to exceed USD 122.69 billion by the end of 2037, growing at over 8.1% CAGR during the forecast period i.e., between 2025-2037. The growing digital drug delivery and increasing prevalence of chronic diseases will propel the market growth.

Europe industry is anticipated to maintain a sizable revenue share by 2037, owing to growing recognition of cutting-edge medication delivery methods and acceptance of cutting-edge technology in the region.

The major players in the market include BD (Becton, Dickinson, and Company), Gerreshelmer AG, Baxter, Nemara, Kindeva Drug Delivery, West Pharmaceutical Services Inc., Ypsomed, Medtronic Inc., E3D Elcam Drug Delivery Devices, Astra Zeneca, Merck KGaA.

Drug Delivery Systems Market Share